Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

Item
http://www.wikidata.org/entity/Q38255161
Emerging treatment approaches for myeloma-related bone disease.A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay.MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells.Pathogenesis of bone disease in multiple myeloma: from bench to bedside.Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
P2860

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

Item
http://www.wikidata.org/entity/Q38255161
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
@en
type
label
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
@en
prefLabel
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932